Abstract
During the last two years following the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, development of potent antiviral drugs and vaccines has been a global health priority. In this context, the understanding of virus pathophysiology, the identification of associated therapeutic targets, and the screening of potential effective compounds have been indispensable advancements. It was therefore of primary importance to develop experimental models that recapitulate the aspects of the human disease in the best way possible. This article reviews the information concerning available SARS-CoV-2 preclinical models during that time, including cell-based approaches and animal models. We discuss their evolution, their advantages, and drawbacks, as well as their relevance to drug effectiveness evaluation.
Subject
Virology,Infectious Diseases
Reference250 articles.
1. SARS-CoV-2: an Emerging Coronavirus that Causes a Global Threat
2. WHO Coronavirus (COVID-19) Dashboard
https://covid19.who.int
3. Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model
4. Transmission of SARS-CoV-2: Implications for Infection Prevention Precautions
https://www.who.int/news-room/commentaries/detail/transmission-of-SARS-CoV-2-implications-for-infection-prevention-precautions
5. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献